Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-04-22
2000-12-05
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514278, 514336, 546 15, 5462804, 5462844, 546339, C07D21346, C07D21350, A61K 314418
Patent
active
061567612
ABSTRACT:
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof: ##STR1## wherein A, B, R2, R3 and q are as defined in the disclosure, pharmaceutical compositions containing them; methods for their production; their use in therapy and methods of treatment of disease states where cognition enhancement is required, such as Alzheimer's disease.
REFERENCES:
patent: 6048877 (2000-04-01), Ahmad et al.
Damasio, Alzheimer's Disease and related Dementias, Cecil Textbook of Medicine, 20th Edition, vol. 2, pp. 1992-1996, 1996.
Van Rhee, et al., J. Med. Chem., 39: 398-406 (1996).
Bryant Helen Jane
Chambers Mark Stuart
Hobbs Sarah Christine
Lee Shu M.
Merck Sharpe & Dohme Limited
Rao Deepak R.
Rose David L.
Shah Mukund J.
LandOfFree
Substituted tetralone derivatives for enhancing cognition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted tetralone derivatives for enhancing cognition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted tetralone derivatives for enhancing cognition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-962021